Which hedge funds own INM? INMED PHARMACEUTICALS INC, Q2 2026 13F holders
11 of the hedge funds tracked by WhaleCreep disclosed a position in INM (INMED PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $2.8m in total. The largest holder by portfolio weight is Sabby Management, LLC at 0.6% of its book. 9 managers opened a new position this quarter: Squadron Capital Management LLC, Ikarian Capital, LLC, Adar1 Capital Management, LLC, Ursa Fund Management, LLC.
11tracked managers holding
9opened this quarter
0exited this quarter
Which hedge funds hold INM? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Sabby Management, LLC | Q2 2026 | 0.6% | $69.7k | 44,970 | -80% | reduced |
| Squadron Capital Management LLC | Q2 2026 | 0.2% | $503.8k | 325,000 | – | new |
| Ikarian Capital, LLC | Q2 2026 | 0.1% | $379.8k | 245,025 | – | new |
| Adar1 Capital Management, LLC | Q2 2026 | 0.1% | $1.2m | 800,000 | – | new |
| Ursa Fund Management, LLC | Q2 2026 | 0.0% | $195.0k | 125,800 | – | new |
| Scientech Research LLC | Q2 2026 | 0.0% | $24.0k | 15,461 | – | new |
| Montanova Capital, LLC | Q2 2026 | 0.0% | $155.0k | 100,000 | – | new |
| Boothbay Fund Management, LLC | Q2 2026 | 0.0% | $115.1k | 74,244 | – | new |
| Seven Grand Managers, LLC | Q2 2026 | 0.0% | $38.8k | 25,000 | – | new |
| Venrock Adviser, LLC | Q2 2026 | 0.0% | $50.7k | 32,685 | – | new |
| Citadel Advisors LLC | Q2 2026 | 0.0% | $40.4k | 26,084 | -44% | reduced |
How has hedge fund ownership of INM changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 11 | $2.8m |
| Q1 2026 | 2 | $172.3k |
| Q3 2025 | 1 | $36.8k |
| Q3 2024 | 1 | $11.9k |
| Q1 2024 | 1 | $10.0k |
| Q4 2023 | 1 | $16.0k |
| Q1 2023 | 1 | $84.0k |
| Q2 2022 | 1 | $23.0k |
| Q1 2022 | 1 | $43.0k |
| Q4 2021 | 1 | $58.0k |
Counts every tracked manager that disclosed INM in that quarter's filing, including managers that have since stopped filing.